Evaluation of a Commercially Available Rapid RT-PCR Assay’s Detection of SARS-CoV-2 Novel Variants

Lewis Back, Jennifer K. Logue, Caitlin R. Wolf, Peter D. Han, Lea M. Starita, Helen Y. Chu
doi: https://doi.org/10.1101/2023.01.30.23285171

Article Information

doi 
https://doi.org/10.1101/2023.01.30.23285171
History 
  • February 1, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Lewis Back, BS1,
  2. Jennifer K. Logue, BS,1,
  3. Caitlin R. Wolf, BS1,
  4. Peter D. Han, MS2,3,
  5. Lea M. Starita, PhD2,3 and
  6. Helen Y. Chu, MD, MPH1,*
  1. 1Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle (98195), Washington, USA
  2. 2Brotman Baty Institute for Precision Medicine, Seattle (98195), Washington, USA
  3. 3Department of Genome Sciences, University of Washington, Seattle (98195), Washington, USA
  1. ↵*Corresponding author; email: helenchu{at}uw.edu
Back to top
Posted February 01, 2023.
Download PDF
Data/Code
Email
Evaluation of a Commercially Available Rapid RT-PCR Assay’s Detection of SARS-CoV-2 Novel Variants
Lewis Back, Jennifer K. Logue, Caitlin R. Wolf, Peter D. Han, Lea M. Starita, Helen Y. Chu
medRxiv 2023.01.30.23285171; doi: https://doi.org/10.1101/2023.01.30.23285171
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area